bufalin has been researched along with Cancer of Cervix in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, X; Li, H; Li, J; Liu, F; Liu, M; Tong, D; Wang, Z | 1 |
Fan, C; Fan, J; Feng, L; Guo, D; Liu, X; Pan, S; Wang, Y | 1 |
2 other study(ies) available for bufalin and Cancer of Cervix
Article | Year |
---|---|
Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Bufanolides; Cell Cycle; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Drug Synergism; Female; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Humans; Integrin alpha2; Integrin beta Chains; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
[Study on proteomics of Hela cell apoptosis in bufalin-induced human cervical carcinoma].
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Cell Line, Tumor; Female; HeLa Cells; Humans; Neoplasm Proteins; Proteomics; Uterine Cervical Neoplasms | 2012 |